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Figures S1- S4   Y78  S168  R313  L319  G360  Q366  P444  N451  G85  N223  Y314  P320  G361  H385  T445  Q452  G86  S263  S315  Q321  N362  V388  A447  N453  A88  L309  L316  Y322  F363  Q389  E448  I454  I165  Q311  R317  N347  L364  L392  Q449  N455  G166  D312  C318  H359  G365  F443 
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Tables S1-S4 S6 Table S2 . AvPAL variants with D-formation activity higher or similar to the wild type (positive hits from the solid-phase screening, verified by HPLC analysis). H359D  V388G  Q366H  H359A  V388T  S315P  H359L  F450G  S263G  F450A  L319V  F450G  H359Q  V388M  Y322A  S456P  F450M  V388Q  H359C  P444C  R313G  Q449D  F450L  S263N  L364H  Q366S  T445I  L392H  L364M  L392N  F450H  H359E  Q366E  L392F  S315G  N453G  Q366P  N453H  N453A  H385G  S263C  L392M  I454T  L392T  N453A  H385C  P444A  Q321H  H385Q  F443A  I454L  H385M  S263N  N453G  F450S  Q389G  V388I  N347T  L392Q   Table S3 . AvPAL variants with no D-formation activity (negative hits from the solid-phase screening, verified by HPLC analysis). Q321E  Q452L  Y78F  N451R  Y78H  I454Y  I165R  F363R  S456R  T445R  F363P  Y78D  N362E  A88R  G361V  Q452L  Q449R  Y78A  L392P  F443K  S263R  Q452K  N223Y  G365D  Q452N  Y78I  R317L  Q389R  Q389P  G85R  N347C  N362R  F443H  Y78P S7 
F450C

F443R
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Experimental section
General methods
Analytical grade reagents were obtained from Sigma-Aldrich, AlfaAesar or Fisher Scientific and used as received from the supplier.
Reverse phase HPLC was performed on an Agilent system equipped with a G1379A degasser, G1312A binary pump, a G1329 autosampler unit, a G1316A temperature controlled column compartment and a G1315B diode array detector.
Conversions were monitored by reverse phase HPLC on a Zorbax Extend-C18 column (50 mm × 4.6 mm × 3.5 μm, Agilent 
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The pET16b-AvPAL plasmid containing the pal gene from Anabaena variabilis, codon-optimised for E.
coli, was obtained as described previously. [1] This plasmid was used as a starting template for the production of the AvPAL single-point mutants library (provided by Codexis, Inc.).
The pRSF-DAAO plasmid containing the daao gene from Trigonopsis variabilis was obtained as described previously. [2] The pma gene from Proteus mirabilis, codon-optimised for E. coli, was synthesised by Geneart and cloned in pET-28a (Novagen) at the restriction sites NdeI and HindIII. The resulting pET28a-LAAD plasmid, checked by sequencing, was used to transform competent E. coli cells.
Antibiotics were added where appropriate to the following final concentrations: ampicillin (Amp) 100
μg mL -1 , kanamycin (Kan) 60 μg mL -1 . Solid media were prepared by addition of agar (1.5% w/v) to liquid media. overnight. The membranes were removed from the plates and dipped three times in liquid nitrogen for 1-2 s, to achieve partial lysis. Then they were placed on filter paper soaked with a solution of HRP (1 mg mL -1 in KPi buffer 100 mM, pH 8.0) and incubated at r. t. for 1 h. The assay solution was prepared adding HRP solution (300 µL, 1 mg mL -1 in KPi buffer 100 mM, pH 8.0) and DAB (1.2 mL, 2
SigmaFast tablets, Sigma-Aldrich, dissolved in 2 mL KPi buffer 100 mM, pH 8.0 + 2 mL NH4OH 5 M pH 9.6 in an ultrasonic bath and filtered) to a solution of the substrate (1.5 mL, 20 mM in NH4OH 5 M pH 9.6). Quantities are given per membrane. The assay was performed by transferring the membranes to a Petri dish containing a filter paper disk soaked in the assay solution and incubating at room temperature until the colour had developed. Clones were picked with sterile toothpicks and transferred to 96-deep-well plates containing 1 mL of LB medium with ampicillin, and grown overnight at 37°C and 220 rpm.
